trial · primary record
4SCAR T cells
Autoimmune Diseases
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2030-12-31 |
| Primary endpoint | Safety of 4SCAR T cells in patients with autoimmune diseases |
| Registry ID | NCT05459870 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:59.256Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05459870
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- 4SCAR T cells · compound